Home › Growth › CJC-1295 No DAC (5mg)
Growth Research Peptide
CJC-1295 No DAC (5mg)
Modified GRF 1-29 · Research-grade, Australia
In stock · dispatched Australia-wide
View & buy on store →About CJC-1295 No DAC
CJC-1295 No DAC (Modified GRF 1-29) is a synthetic analogue of growth hormone-releasing hormone (GHRH) comprising the first 29 amino acids of endogenous GHRH. Its short half-life produces a pulsatile pattern of GH release; this 5mg presentation is commonly studied alongside Ipamorelin in laboratory settings.
Within the research community it is studied in laboratory and pre-clinical models. It is supplied by Vital Research Labs strictly as a reference compound for in-vitro laboratory investigation.
Molecular & physical profile
| Compound | CJC-1295 No DAC |
|---|---|
| Category | Growth |
| CAS Number | 863288-34-0 |
| Form | Lyophilised Powder |
| Appearance | White to off-white solid |
| Purity | 99.753% (this batch) |
| Batch | CS-noda5-0116 |
| Analytical methods | HPLC (purity), mass spectrometry (identity) |
| Solubility (research) | Reconstitutes in bacteriostatic or sterile water |
Batch-specific analytical values are recorded on the Certificate of Analysis supplied with the compound.
Reconstitution & handling
CJC-1295 No DAC is supplied as a lyophilised (freeze-dried) powder. For research handling it is typically reconstituted with bacteriostatic water; the exact volume depends on the concentration a given research protocol calls for. Our reconstitution calculator can be used to work out volumes for a target research concentration. Handle under appropriate laboratory conditions and avoid repeated freeze–thaw cycles of the reconstituted solution.
Storage & stability
- Lyophilised powder — -20 °C — protect from light & moisture.
- Reconstituted solution — 2–8 °C — use within 28 days.
- Handling — minimise freeze–thaw cycles; keep vials sealed until use.
Quality & testing
Every batch supplied by Vital Research Labs is analysed by an independent third-party laboratory. Purity is confirmed by high-performance liquid chromatography (HPLC) and identity by mass spectrometry (MS). This batch is verified at 99.753% purity, and a Certificate of Analysis is available for the batch so researchers can verify exactly what they are working with.
Shipping within Australia
CJC-1295 No DAC is dispatched from within Australia to Australian research customers, packaged discreetly and appropriately for a lyophilised research compound. Orders are processed on receipt of payment via bank transfer.
Frequently asked questions
Is CJC-1295 No DAC (5mg) available in Australia for research?
Yes. Vital Research Labs supplies research-grade CJC-1295 No DAC (5mg) to Australian research customers, dispatched domestically. It is provided strictly for in-vitro laboratory research and is not for human or veterinary use.
What purity is your CJC-1295 No DAC (5mg)?
This batch is verified at 99.753% purity by third-party analytical testing (HPLC for purity, mass spectrometry for identity). A Certificate of Analysis is available for the batch.
How is CJC-1295 No DAC (5mg) tested?
Each batch is analysed by an independent third-party laboratory using HPLC to confirm purity and mass spectrometry to confirm identity. Batch-specific values are recorded on the Certificate of Analysis.
How should CJC-1295 No DAC (5mg) be stored?
The lyophilised powder is stored at -20 degrees C, protected from light and moisture. Once reconstituted for research it is kept at 2-8 degrees C and typically used within 28 days.
Is CJC-1295 No DAC (5mg) intended for human use?
No. CJC-1295 No DAC (5mg) supplied by Vital Research Labs is intended strictly for in-vitro laboratory research and development. It is not a medicine or therapeutic good and is not for human consumption, veterinary use, or clinical application.